RecruitingEarly Phase 1NCT07341360
Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
Studying Pseudomyxoma peritonei
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oslo University Hospital
- Intervention
- Pseudovax(other)
- Enrollment
- 10 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2034
Study locations (1)
- Oslo University Hospital HF, Radium, Oslo, Oslo County, Norway
Collaborators
BeiGene
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07341360 on ClinicalTrials.govOther trials for Pseudomyxoma peritonei
Additional recruiting or active studies for the same condition.